Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel alkaline salt-assisted cyclization improves Bosutinib yield and purity. Ideal for reliable API supplier partnerships seeking cost reduction.
Novel boron-based method eliminates copper waste ensuring high purity amino acid intermediate for pharma supply chains and significant cost reduction capabilities.
Novel nickel catalyzed method offers mild conditions and high enantioselectivity for pharmaceutical intermediates manufacturing supply chain optimization and cost efficiency.
Novel synthesis method for Fmoc-a-methyl-L-glutamic acid offering high yield and industrial scalability for pharmaceutical intermediate supply chains globally.
Patent CN112125939B reveals a novel acylation and recrystallization route for 5-deoxy-D-ribose, offering superior purity and scalable production for nucleoside drug synthesis.
Advanced synthesis of ertapenem intermediate via CN110698480A. Delivers >99% purity, stable intermediates, and cost reduction in pharmaceutical intermediates manufacturing.
Discover the novel synthetic route for Ulipristal Acetate via patent CN102875629A. Achieve significant cost reduction and enhanced supply chain reliability in steroid manufacturing.
Patent CN106146592B details a high-yield testosterone synthesis. Achieve cost reduction in pharmaceutical intermediates manufacturing with this scalable route.
Patent CN109020862B reveals a Lewis acid-catalyzed synthesis for high-purity 3,4-dihydro-1-pyrroline-N-oxide derivatives, offering significant supply chain and cost advantages.
Patent CN103694176A details a high-yield route for nilotinib intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel cobalt-catalyzed asymmetric hydrosilylation patent CN116554223A offers high enantioselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN103936614A reveals a streamlined method for tiopronin intermediate production, eliminating solvent extraction for cost and environmental benefits.
Patent CN104313064A details a high-yield biocatalytic route for chiral esters. Discover cost-effective, scalable manufacturing for pharmaceutical intermediates.
Patent CN117229137A reveals a high-yield naproxen process using organic amine catalysts. This method ensures high purity and reduced waste for supply chain stability.
Patent CN105418567B enables high-purity beraprost production. Discover cost-effective, scalable routes for pharmaceutical intermediates and supply chain optimization.
Patent CN109456952B reveals a novel omega-transaminase mutant for Sitafloxacin intermediates. Discover cost-effective, scalable biocatalytic solutions for high-purity chiral amine production.
Advanced 7-step synthesis of 17S-pancuronium bromide from sisal sapogenin. Delivers high-purity API intermediates with optimized cost reduction in API manufacturing.
Patent CN113773241A details a novel Pd/Al2O3 catalytic route for N-methyl indole, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Discover the novel one-pot synthesis for quinolone intermediates described in patent CN114702443B. This method offers significant supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN117677616A reveals a robust synthesis route for hemoglobin modulators offering improved purity and supply chain reliability for pharmaceutical partners.